{{Infobox drug
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 470602455
| IUPAC_name = 4,4'-{1,4-phenylenebis[(E)methylylidene
(E)azanylylidene]}bis(1,2-oxazolidin-3-one)
| image = Terizidone.svg
| image_class = skin-invert-image
| width = 275
| alt =
| tradename = Terivalidin
| Drugs.com =
| pregnancy_AU =
| pregnancy_category =
| routes_of_administration =
| ATC_prefix = J04
| ATC_suffix = AK03
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref =
| CAS_number = 25683-71-0
| PubChem = 65720
| DrugBank_Ref =
| DrugBank =
| ChemSpiderID_Ref =
| ChemSpiderID = 59144
| UNII_Ref =
| UNII = 1199LEX5N8
| KEGG_Ref =
| KEGG = D07247
| C=14 | H=14 | N=4 | O=4
| smiles = O=C3NOCC3/N=C/c2ccc(/C=N/C1C(=O)NOC1)cc2
| StdInChI_Ref =
| StdInChI = 1S/C14H14N4O4/c19-13-11(7-21-17-13)15-5-9-1-2-10(4-3-9)6-16-12-8-22-18-14(12)20/h1-6,11-12H,7-8H2,(H,17,19)(H,18,20)/b15-5+,16-6+
| StdInChIKey_Ref =
| StdInChIKey = ODKYYBOHSVLGNU-IAGONARPSA-N
| synonyms = 4-[({4-[N-(3-oxo-1,2-oxazolidin-4-yl)carboximidoyl]phenyl}methylidene)amino]-1,2-oxazolidin-3-one
}}
特立齊酮(INN:terizidone) 是一種用於治療結核病的藥物。它主要與其他二線藥物併用,治療多重抗藥性結核病(MDR-TB)。它是環絲胺酸的衍生物,具有抑菌活性。
此藥物為世界衛生組織基本藥物標準清單中的一種治療替代方案。
引用文獻
亞胺
抗結核藥物
世界衛生組織基本藥物
评论 (0)